COFCO Biotechnology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	1,817	2,488	1,909	1,481	1,017	1,116
Trading Asset Securities	-	-	-	-	3.82	1.86
Cash & Short-Term Investments	1,817	2,488	1,909	1,481	1,020	1,118
Cash Growth	1.15%	30.30%	28.91%	45.14%	-8.71%	68.77%
Accounts Receivable	1,326	951.94	1,277	1,124	1,370	1,189
Other Receivables	154.44	99.77	114.69	196	168.42	293.76
Receivables	1,480	1,052	1,392	1,320	1,538	1,483
Inventory	2,780	1,886	2,770	2,534	3,763	4,052
Other Current Assets	918.81	694.77	739.34	700.37	1,349	982.02
Total Current Assets	6,997	6,120	6,810	6,035	7,671	7,635
Property, Plant & Equipment	8,752	8,749	8,590	8,632	8,611	8,515
Long-Term Investments	437.57	446.39	548.06	535.39	536.93	512.12
Goodwill	366.04	366.04	366.04	366.04	366.04	366.04
Other Intangible Assets	617.96	624.56	601.01	601.15	609.08	628.96
Long-Term Deferred Tax Assets	335.75	328.03	280.07	265.01	193.49	202.99
Long-Term Deferred Charges	47.16	49.97	40.99	41.94	31.31	25.23
Other Long-Term Assets	107.62	83.71	93.07	80.94	110.52	171.76
Total Assets	17,661	16,768	17,329	16,558	18,129	18,057
Accounts Payable	667.77	537.45	728.36	766.49	919.59	920.25
Accrued Expenses	190.88	134.31	250.81	262.96	360.15	418.44
Short-Term Debt	2,505	1,864	4,000	3,217	2,874	2,764
Current Portion of Long-Term Debt	-	42.62	61.41	44.93	42.67	86.61
Current Portion of Leases	-	-	17.95	19.18	12.08	20.81
Current Income Taxes Payable	-	70.73	46.57	47.59	61.58	35
Current Unearned Revenue	356.64	187.85	223.88	266.39	278.73	328.64
Other Current Liabilities	2,261	2,182	507.86	517.47	612.33	1,015
Total Current Liabilities	5,981	5,019	5,837	5,142	5,162	5,589
Long-Term Debt	509.02	367.8	165.1	165.65	191.28	406.4
Long-Term Leases	160.36	158.32	177.11	196.64	105.63	117.3
Long-Term Unearned Revenue	98.35	70.08	99.73	70.01	72.6	113.79
Long-Term Deferred Tax Liabilities	44.64	44.7	66.39	89	60.89	32.07
Other Long-Term Liabilities	61.9	93.05	67.8	41.19	27.33	43.32
Total Liabilities	6,856	5,753	6,413	5,704	5,619	6,302
Common Stock	1,856	1,856	1,860	1,865	1,865	1,866
Additional Paid-In Capital	6,088	6,088	6,102	6,126	6,135	6,131
Retained Earnings	1,786	1,908	1,810	1,784	3,449	2,847
Treasury Stock	-	-	-13.2	-33.31	-43.03	-66.89
Comprehensive Income & Other	674.06	759.46	760.14	709.5	692.84	616.89
Total Common Equity	10,405	10,611	10,518	10,452	12,098	11,394
Minority Interest	400.26	403.39	398.22	401.96	411.53	361.42
Shareholders' Equity	10,805	11,015	10,916	10,854	12,510	11,755
Total Liabilities & Equity	17,661	16,768	17,329	16,558	18,129	18,057
Total Debt	3,175	2,433	4,421	3,643	3,226	3,395
Net Cash (Debt)	-1,357	54.96	-2,512	-2,162	-2,206	-2,278
Net Cash Per Share	-0.73	0.03	-1.35	-1.17	-1.19	-1.23
Filing Date Shares Outstanding	1,857	1,851	1,860	1,865	1,865	1,866
Total Common Shares Outstanding	1,857	1,851	1,860	1,865	1,865	1,866
Working Capital	1,015	1,101	973.45	893.51	2,509	2,046
Book Value Per Share	5.60	5.73	5.66	5.60	6.49	6.11
Tangible Book Value	9,421	9,621	9,551	9,484	11,123	10,399
Tangible Book Value Per Share	5.07	5.20	5.14	5.09	5.96	5.57
Buildings	-	-	4,530	4,447	4,678	4,534
Machinery	-	-	9,785	9,495	9,830	9,025
Construction In Progress	-	-	350.05	312.19	84.39	720.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.